Recruiting Deep Vein Thrombosis Studies in Washington D.c.
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with ...
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagu...
About Deep Vein Thrombosis Clinical Trials in Washington D.c.
Deep vein thrombosis (DVT) occurs when a blood clot forms in a deep vein, usually in the legs. It can be dangerous if the clot breaks loose and travels to the lungs (pulmonary embolism). Treatment includes blood thinners and sometimes clot-removal procedures.
There are currently 2 deep vein thrombosis clinical trials recruiting participants in Washington D.c., DC. These studies are seeking a combined 1,348 participants. Research is being sponsored by Anthos Therapeutics, Inc., Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Deep Vein Thrombosis Clinical Trials in Washington D.c. — FAQ
Are there deep vein thrombosis clinical trials in Washington D.c.?
Yes, there are 2 deep vein thrombosis clinical trials currently recruiting in Washington D.c., DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washington D.c.?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.c. research site will contact you about next steps.
Are clinical trials in Washington D.c. free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.c. studies also compensate for your time and travel.
What deep vein thrombosis treatments are being tested?
The 2 active trials in Washington D.c. are testing new therapies including novel drugs, biologics, and treatment approaches for deep vein thrombosis.
Data updated March 2, 2026 from ClinicalTrials.gov